{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:07:22Z","timestamp":1779782842526,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05505-7","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:31:19Z","timestamp":1778232679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of upfront HA-WBRT vs. SRS for treatment of brain metastases due to SCLC"],"prefix":"10.1007","volume":"177","author":[{"given":"Keshav","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqi","family":"Pollom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"5505_CR1","unstructured":"American Cancer Society. Key statistics for lung cancer (2025) https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html"},{"issue":"16suppl","key":"5505_CR2","doi-asserted-by":"publisher","first-page":"e20617","DOI":"10.1200\/JCO.2022.40.16_suppl.e20617","volume":"40","author":"P Cockrum","year":"2022","unstructured":"Cockrum P, MacEwan JP, Ramirez RA (2022) Treatment patterns and outcomes associated with small cell lung cancer by platinum sensitivity status in a U.S. Medicare population. J Clin Oncol 40(16suppl):e20617\u2013e20617. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.e20617","journal-title":"J Clin Oncol"},{"issue":"13","key":"5505_CR3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jama.2009.1409","volume":"302","author":"FM Clement","year":"2009","unstructured":"Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ (2009) Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions: A Comparison of Britain, Australia, and Canada. JAMA 302(13):1437. https:\/\/doi.org\/10.1001\/jama.2009.1409","journal-title":"JAMA"},{"issue":"10","key":"5505_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S et al (2020) Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol 38(10):1019\u20131029. https:\/\/doi.org\/10.1200\/JCO.19.02767","journal-title":"J Clin Oncol"},{"key":"5505_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-71070-9","volume-title":"Principles and Practice of Stereotactic Radiosurgery","year":"2008","unstructured":"Chin LS, Regine WF (eds) (2008) Principles and Practice of Stereotactic Radiosurgery. Springer, New York. https:\/\/doi.org\/10.1007\/978-0-387-71070-9"},{"issue":"20","key":"5505_CR6","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1200\/JCO.22.00333","volume":"40","author":"D Schiff","year":"2022","unstructured":"Schiff D, Messersmith H, Brastianos PK et al (2022) Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. J Clin Oncol 40(20):2271\u20132276. https:\/\/doi.org\/10.1200\/JCO.22.00333","journal-title":"J Clin Oncol"},{"issue":"11","key":"5505_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"issue":"4","key":"5505_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316(4):401. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"5505_CR9","unstructured":"Jing Li. Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4\u201315 brain metastases: a phase III randomized controlled trial. Presented at: ASTRO, Online (2020) https:\/\/www.astro.org\/ASTRO\/media\/ASTRO\/News%20and%20Publications\/Press%20Kits\/PDFs\/2020\/AM20_PressSlidesLi41.pdf"},{"issue":"1","key":"5505_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijrobp.2017.04.037","volume":"99","author":"M Yamamoto","year":"2017","unstructured":"Yamamoto M, Serizawa T, Higuchi Y et al (2017) A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores. Int J Radiat Oncol 99(1):31\u201340. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.04.037","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"5505_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/COC.0b013e3182005a8f","volume":"35","author":"LS Lal","year":"2012","unstructured":"Lal LS, Byfield SD, Chang EL et al (2012) Cost-effectiveness Analysis of a Randomized Study Comparing Radiosurgery With Radiosurgery and Whole Brain Radiation Therapy in Patients With 1 to 3 Brain Metastases. Am J Clin Oncol 35(1):45\u201350. https:\/\/doi.org\/10.1097\/COC.0b013e3182005a8f","journal-title":"Am J Clin Oncol"},{"key":"5505_CR12","unstructured":"Joe Y, Chang S, Senan M, Paul R, Mehran A, Louie, Peter Balter. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. 2045. https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-1570168-3\/abstract"},{"issue":"Supplement1","key":"5505_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/2016.7.GKS161499","volume":"125","author":"NH Lester-Coll","year":"2016","unstructured":"Lester-Coll NH, Dosoretz AP, Magnuson WJ, Laurans MS, Chiang VL, Yu JB (2016) Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. J Neurosurg 125(Supplement1):18\u201325. https:\/\/doi.org\/10.3171\/2016.7.GKS161499","journal-title":"J Neurosurg"},{"key":"5505_CR14","unstructured":"Vinai Gondi (2025) Testing if high dose radiation only to the sites of brain cancer compared to whole brain radiation that avoids the hippocampus is better at preventing loss of memory and thinking ability. Northwestern Feinberg School of Medicine. https:\/\/clinicaltrials.gov\/study\/NCT04804644"},{"key":"5505_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2019.00205","volume":"9","author":"M Khan","year":"2019","unstructured":"Khan M, Lin J, Liao G et al (2019) Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors. Front Oncol 9:205. https:\/\/doi.org\/10.3389\/fonc.2019.00205","journal-title":"Front Oncol"},{"issue":"12","key":"5505_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jamaoncol.2022.5049","volume":"8","author":"JD Palmer","year":"2022","unstructured":"Palmer JD, Klamer BG, Ballman KV et al (2022) Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C\/CEC.3 (Alliance for Clinical Trials in Oncology\/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol 8(12):1809. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5049","journal-title":"JAMA Oncol"},{"issue":"1","key":"5505_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12885-015-1103-6","volume":"15","author":"S Yomo","year":"2015","unstructured":"Yomo S, Hayashi M (2015) Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients. BMC Cancer 15(1):95. https:\/\/doi.org\/10.1186\/s12885-015-1103-6","journal-title":"BMC Cancer"},{"issue":"9422","key":"5505_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665\u20131672. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8","journal-title":"Lancet"},{"issue":"23","key":"5505_CR19","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1002\/cncr.29642","volume":"121","author":"ST Savitz","year":"2015","unstructured":"Savitz ST, Chen RC, Sher DJ (2015) Cost-effectiveness analysis of neurocognitive\u2010sparing treatments for brain metastases. Cancer 121(23):4231\u20134239. https:\/\/doi.org\/10.1002\/cncr.29642","journal-title":"Cancer"},{"key":"5505_CR20","unstructured":"CMS.gov. Physician Fee Schedule Menu. Published online October 17, 2024. https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search?Y=0%26;T=0%26HT=0%26CT=3%26H1=99233%26M=5"},{"issue":"Suppl2","key":"5505_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3171\/2014.7.GKS14972","volume":"121","author":"MD Hall","year":"2014","unstructured":"Hall MD, McGee JL, McGee MC et al (2014) Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases: Clinical article. J Neurosurg 121(Suppl2):84\u201390. https:\/\/doi.org\/10.3171\/2014.7.GKS14972","journal-title":"J Neurosurg"},{"key":"5505_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2019.01.019","volume":"130","author":"K Zhou","year":"2019","unstructured":"Zhou K, Zhou J, Huang J et al (2019) Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer. Lung Cancer 130:1\u20134. https:\/\/doi.org\/10.1016\/j.lungcan.2019.01.019","journal-title":"Lung Cancer"},{"issue":"6S","key":"5505_CR23","doi-asserted-by":"publisher","first-page":"75s","DOI":"10.1200\/JOP.2011.000469","volume":"8","author":"B Chastek","year":"2012","unstructured":"Chastek B, Harley C, Kallich J, Newcomer L, Paoli CJ, Teitelbaum AH (2012) Health Care Costs for Patients With Cancer at the End of Life. J Oncol Pract 8(6S):75s\u201380s. https:\/\/doi.org\/10.1200\/JOP.2011.000469","journal-title":"J Oncol Pract"},{"key":"5505_CR24","unstructured":"Drugs.com memantine prices, coupons, copay cards & patient assistance. https:\/\/www.drugs.com\/price-guide\/memantine."},{"key":"5505_CR25","doi-asserted-by":"publisher","unstructured":"Garside R, Pitt M, Anderson R et al (2007) The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess 11(45). https:\/\/doi.org\/10.3310\/hta11450","DOI":"10.3310\/hta11450"},{"key":"5505_CR26","doi-asserted-by":"crossref","unstructured":"Wilson J, Yao GL, Raftery J et al (2007) A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Published online. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK62325\/","DOI":"10.3310\/hta11130"},{"issue":"1","key":"5505_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jval.2013.10.009","volume":"17","author":"M Oremus","year":"2014","unstructured":"Oremus M, Tarride JE, Clayton N, Raina P (2014) Health Utility Scores in Alzheimer\u2019s Disease: Differences Based on Calculation With American and Canadian Preference Weights. Value Health 17(1):77\u201383. https:\/\/doi.org\/10.1016\/j.jval.2013.10.009","journal-title":"Value Health"},{"issue":"7","key":"5505_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","volume":"6","author":"CG Rusthoven","year":"2020","unstructured":"Rusthoven CG, Yamamoto M, Bernhardt D et al (2020) Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. JAMA Oncol 6(7):1028. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1271","journal-title":"JAMA Oncol"},{"issue":"4","key":"5505_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/nop\/npac093","volume":"10","author":"VE Chen","year":"2023","unstructured":"Chen VE, Kim M, Nelson N, Kim IK, Shi W (2023) Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases. Neuro-Oncol Pract 10(4):344\u2013351. https:\/\/doi.org\/10.1093\/nop\/npac093","journal-title":"Neuro-Oncol Pract"},{"issue":"1","key":"5505_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12885-020-06800-w","volume":"20","author":"K Mitsuya","year":"2020","unstructured":"Mitsuya K, Nakasu Y, Hayashi N et al (2020) Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factors. BMC Cancer 20(1):331. https:\/\/doi.org\/10.1186\/s12885-020-06800-w","journal-title":"BMC Cancer"},{"key":"5505_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2017.00279","volume":"7","author":"N Rana","year":"2017","unstructured":"Rana N, Pendyala P, Cleary RK et al (2017) Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases. Front Oncol 7:279. https:\/\/doi.org\/10.3389\/fonc.2017.00279","journal-title":"Front Oncol"},{"issue":"1","key":"5505_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","volume":"127","author":"WH McKay","year":"2017","unstructured":"McKay WH, McTyre ER, Okoukoni C et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127(1):148\u2013156. https:\/\/doi.org\/10.3171\/2016.5.JNS153051","journal-title":"J Neurosurg"},{"issue":"3","key":"5505_CR33","doi-asserted-by":"publisher","first-page":"101720","DOI":"10.1016\/j.adro.2025.101720","volume":"10","author":"J Desai","year":"2025","unstructured":"Desai J, Rajkumar S, Shepard MJ, Wegner RE (2025) National Trends in Radiation Treatment for Small Cell Lung Cancer Brain Metastases in the Modern Era. Adv Radiat Oncol 10(3):101720. https:\/\/doi.org\/10.1016\/j.adro.2025.101720","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"5505_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.wneu.2015.06.021","volume":"84","author":"KT Kimmell","year":"2015","unstructured":"Kimmell KT, LaSota E, Weil RJ, Marko NF (2015) Comparative Effectiveness Analysis of Treatment Options for Single Brain Metastasis. World Neurosurg 84(5):1316\u20131332. https:\/\/doi.org\/10.1016\/j.wneu.2015.06.021","journal-title":"World Neurosurg"},{"issue":"6","key":"5505_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630\u2013637. https:\/\/doi.org\/10.1016\/S1470-2045(15)70168-3","journal-title":"Lancet Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05505-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:57:27Z","timestamp":1779782247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5505"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05505-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}